Marijuana could regulate the main gateway COVID-19 enters host cells in patients, new research concludes.
New research into preventive measure and possible treatment to the novel coronavirus has yielded an unlikely candidate — cannabis. At the pandemic’s start, public health officials warned inhalation of combustible marijuana could make individuals more susceptible to contracting the coronavirus and worsen illness symptoms. This hypothesis came from preliminary data out of China and Italy where underlying lung disease correlated with more hospitalized COVID-19 patients.
A new study published in the journal Preprints, which is not peer-reviewed, finds certain marijuana strains could prevent the spread and severity of COVID-19. It’s all tied to how the coronavirus is transmitted between patients. Like most respiratory illnesses, tiny droplets carrying the disease expelled by coughing or sneezing go airborne. Once a non-infected patient inhales those droplets, it typically enters your body through cells in your lungs and corresponding tissue.
The scientific community has recently identified the ACE2 protein as the primary gateway the coronavirus infects patients. Researchers suspect modulating the level of proteins present in a patient could prevent susceptibility to the disease. In a study completed before the pandemic, researchers had observed the combination of THC and CBD cannabinoids could lower gene expressions that produce and regulate ACE2 proteins.